最近结核病治疗方面的进展
Ilaria Motta1, Martin Boeree2, Dumitru Chesov3
1Médecins Sans Frontières, Manson Unit, London, United Kingdom.
概括
结核病 (TB) 治疗的最新进展为耐药性和耐药性结核病提供了更短的治疗方案. 未来的研究重点是个性化治疗和预防耐药性,以改善患者的治疗结果.
科学领域:
- 传染性疾病 传染性疾病
- 全球健康 全球健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 仍然是全球主要的死亡原因,需要在治疗策略方面取得进展.
- 在过去的十年中,结核病治疗发生了重大变化,有新的药物和有希望的临床试验结果.
- 优化药物剂量和重新定位的药物为有效的结核病治疗方案提供了进一步的潜力.
研究的目的:
- 提供当前对药物敏感性和耐药性结核病治疗的全面概述.
- 总结最近的临床试验结果和正在进行的结核病治疗研究.
- 讨论新疗法对患者结局和结核病计划管理的影响.
主要方法:
- 对PubMed和MEDLINE数据库进行了非系统的文献审查.
- 关于正在进行的临床试验的信息来自各种来源,包括 clinicaltrials.gov.gov.
- 审查的重点是最近的进展,临床试验结果和结核病治疗的未来研究方向.
主要成果:
- 新的化合物如贝达基林,德拉曼尼德和普雷托曼尼德已经出现,在临床试验中显示出有效性.
- 第三阶段试验表明,对药物敏感性和耐药性结核病的治疗时间缩短.
- 目前正在进行的试验探索各种治疗方法,包括宿主导疗法和药物基因组学.
结论:
- 个性化治疗方案对于优化结核病治疗至关重要.
- 预防和检测耐药性对于保持新的结核病治疗疗法的有效性至关重要.
- 确保负担得起,以患者为中心的新型结核病治疗选择的获取对于全球结核病控制至关重要.
关键词:
临床试验临床试验是指临床试验的临床试验.有针对性的治疗.剂量 剂量 剂量主持人 主持人 主持人 主持人异化物耐药性 异化物耐药性在MDR-TB中,使用的是MDR.结核病菌菌菌的结核病菌的结核病菌.新的药物 新的药物优化优化 优化优化药物基因组学 药物基因组学药理动力学 药理动力学在XDR前的结核病.更多相关视频
相关概念视频
01:28Pulmonary Tuberculosis V
202
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
202
01:26Pulmonary Tuberculosis IV
165
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
165
01:29Pulmonary Tuberculosis I
270
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
270
01:31Pulmonary Tuberculosis III
366
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
366
01:28Pulmonary Tuberculosis II
266
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
266
01:28Pneumonia IV: Management
359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359